Serum uric acid level in acute stroke patients

Medical Journal of the Islamic Republic of Iran

Volumn 26, Issue 2, 2012, Pages 66-72

  Mehrpour, Masoud ^a   Khuzan, Mahbubeh ^a   Najimi, Neda ^a   Motamed, Mohamad R ^a   Fereshtehnejad, Seyed Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute stroke; Triglyceride; Uric acid

Indexed keywords

EID: 84865082150     PISSN: 10161430     EISSN: 22516840     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kim SY, Guevara JV, kim KM, et al. Hyperuricemia and Risk of stroke: A Systematic Review and Hariklia VD, Apostolos H, Haralambosk. The Role of Uric Acid in Stroke. The lssue Remains Unresolved. The Neurologist. 2008; 14: 238-242.
2. Hariklia VD, Apostolos H, Haralambosk. The Role of Uric Acid in Stroke. The lssue Remains Unresolved. The Neurologist. 2008; 14: 238-242.
3. Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population- based studies: a systematic review. Lancet Neurol. Llibre J, Valhuerdi A, Fernandez O. prevalence of stroke and Associated Risk factors in Older Adults in Havana city and Matanzas Provinus, Cuba (10/66 Population- Based study). MEDICC Review. 2010; 12: 20-24.
4. Llibre J, valhuerdi A, Fernandez O. prevalence of stroke and Associated Risk factors in Older Adults in Havana city and Matanzas Provinus, Cuba (10/66 Population- Based study). MEDICC Review. 2010; 12: 20-24.
5. Barr WG. Uric acid. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods. The History, Physical, and Laboratory Examination, 3rd ed. Boston: Butter worth: 1990. P: 760-763.
6. Heo SH, Lee SH. High levels of serum Uric acid are associated with silent brain infarctivn. Jaurnal of the Neurol Scien. 2010; 297:6-15.
7. Amaro S, Urra X, Gomez-Choco M. Uric Acid Levels Are Relevant in Patients With Stroke Treated with Thrombolysis. Stroke. 2011; 42:28-32.
8. Ogbera A, Azenabor A. Hyperuricemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr 2010; 2:24-30.
9. Weir CJ, Muir SW, Walters MR, et al. Serum Urate as an independent predictor of poor outcome and future vascular events after acute ischemic stroke. Stroke 2003; 34: 1951-1956
10. Chamorro A, Obach V, Cerrera A, et al. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke. 2002; 33:1048-1052.
11. Romanos E, Planas AM, Amaro S, et al. Uric acid reduces brain damage and improves the benfits of rtPA in a rat model of the thrombo- embolic stroke. J cereb Blood Flow Metab. 2007; 27: 14-20.
12. Yanyan Z, Bhavik P, Hyon C. Prevalence of Hyperuricemia in the US General Population: The National Health and Nutrition Examination Survey (NHANES) 1999-2008. Arthritis and Rheumatism 2010; 62 Suppl 10:1363
13. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public He. Bansal BC, Gupta RR, Bansal MR, et al. Serum lipids and uric acid relationship in ischemic thrombotic cerebrovascular disease. Stroke 1975; 6:304-307alth. 2004;25(4):9.
14. Bansal BC, Gupta RR, Bansal MR, et al. Serum lipids and uric acid relationship in ischemic thrombotic cerebrovascular disease. Stroke 1975; 6:304-307
15. Milionis HJ, Kalantzi KJ, Goudevenos JA, et al. Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med 2005;258:435-41.
16. De Leeum PW, Thijs L, Birkenhager WH, et al. systolic hypertension in Europe (Syst-Eur) trial investigators, Prognostic significance of renal function in elderly patients with isolated systolic hypertension, results from the Syst-Eur trial. Am Soc Nephrol 2002; 13: 2213-2221
17. Sakata K, Hashimoto T, Ueshima H, et al. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994, National integrated projects for prospective observation of non-communicable disease and its trend in the aged. Eur J Epidemiol; 17: 461-468.
18. Goldberg RJ, Burchfiel CM, Benfante R, et al. Life style and biologic factors associated with atherosclrotic disease in middle- aged men.20- year, finding from the Honolulu Heart Program. Arch lntern Med. 1995;155:686-694.
19. Cazzato G, Zorzon M, Mouti F, et al. The blood level of uric acid as a risk factor in transient cerebral ischemic attack and non-embolic acute infarct. Riv Neurol 1982; 52:355-369.
20. Chen Y, Ding X, Teng J, et al. Serum uric acid is inversely relate to acute ischemic stroke morbidity in hemodialysis patients. Am J Nephrol 2011;33(2):97-104.
21. Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study. Am J Epidemiol 1995; 141:637-644.
22. Nicholls A, Snaith ML, Scott JT. Effect of estrogen therapy on plasma and urinary levels of uric acid. BMJ 1973; 1:449-451.
23. Matsubara K, Matsuzawa Y, Jiao S, et al. Relationship between hypertriglyceridemia and uric acid production in primary gout. Metabolism 1989; 38:698-701.
24. Bonora E, Targher G, Zenere MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men, Role of obesity and central fat distribution, The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996; 20(11):975-80.
25. Johnson RJ, Kivlighn SD, Kim YG, et al. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease and renal disease. Am J Kidney Dis 1999; 33:225-234.
26. Ferns GA, Lanham J, Dieppe P, et al. A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridemia of primary gout. Hum Genet 1988; 78:55-59.
27. Moriwaki Y, Tetsuya Y, Takahashi S, et al. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridemia. Ann Rheum Dis 1995; 54:351-354
28. Hozawa A, Folsom AR, Ibrahim H, et al. Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis 2006;187(2):401-407
29. Bos MJ, Koudstaal PJ, Hofman A, et al. Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke. The Rotterdam Study. Stroke 2006;37:1503-1507.
30. Amaro S, Soy D, Obach V, et al. A Pilot Study of Dual Treatment With Recombinant Tissue Plasminogen Activator and Uric Acid in Acute Ischemic Stroke. Stroke 2007; 38(7):2173-5.